1. Home
  2. TMCI vs FTHY Comparison

TMCI vs FTHY Comparison

Compare TMCI & FTHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • FTHY
  • Stock Information
  • Founded
  • TMCI 2014
  • FTHY 2020
  • Country
  • TMCI United States
  • FTHY United States
  • Employees
  • TMCI N/A
  • FTHY N/A
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FTHY Investment Managers
  • Sector
  • TMCI Health Care
  • FTHY Finance
  • Exchange
  • TMCI Nasdaq
  • FTHY Nasdaq
  • Market Cap
  • TMCI 464.4M
  • FTHY 529.9M
  • IPO Year
  • TMCI 2021
  • FTHY N/A
  • Fundamental
  • Price
  • TMCI $8.71
  • FTHY $14.50
  • Analyst Decision
  • TMCI Hold
  • FTHY
  • Analyst Count
  • TMCI 8
  • FTHY 0
  • Target Price
  • TMCI $8.84
  • FTHY N/A
  • AVG Volume (30 Days)
  • TMCI 291.6K
  • FTHY 176.7K
  • Earning Date
  • TMCI 02-27-2025
  • FTHY 01-01-0001
  • Dividend Yield
  • TMCI N/A
  • FTHY 10.93%
  • EPS Growth
  • TMCI N/A
  • FTHY N/A
  • EPS
  • TMCI N/A
  • FTHY N/A
  • Revenue
  • TMCI $202,861,000.00
  • FTHY N/A
  • Revenue This Year
  • TMCI $13.18
  • FTHY N/A
  • Revenue Next Year
  • TMCI $8.61
  • FTHY N/A
  • P/E Ratio
  • TMCI N/A
  • FTHY N/A
  • Revenue Growth
  • TMCI 16.14
  • FTHY N/A
  • 52 Week Low
  • TMCI $3.92
  • FTHY $12.66
  • 52 Week High
  • TMCI $15.98
  • FTHY $14.74
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 63.78
  • FTHY 47.79
  • Support Level
  • TMCI $8.16
  • FTHY $14.33
  • Resistance Level
  • TMCI $8.64
  • FTHY $14.71
  • Average True Range (ATR)
  • TMCI 0.48
  • FTHY 0.15
  • MACD
  • TMCI 0.12
  • FTHY 0.01
  • Stochastic Oscillator
  • TMCI 93.09
  • FTHY 48.78

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

About FTHY First Trust High Yield Opportunities 2027 Term Fund

FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income.

Share on Social Networks: